INS and SHORT syndrome: We thus hypothesised that in SHORT syndrome, the liver is protected from increased insulin-mediated lipogenesis, which is relatively unaffected by common IR [19], and that this explains the absence of dyslipidaemia and fatty liver despite severe IR and lipodystrophy.